Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Engineered chemogenetically-gated ion channels are genetically modified ion channels that can be selectively activated or inhibited by otherwise inert, exogenous small molecules (ligands). These tools allow precise, reversible, and noninvasive control of cellular excitability in specific cell populations—most commonly neurons. Activation leads to ion flow across the membrane altering cell excitability, and the effect can be excitatory or inhibitory depending on the design. Compared to optogenetics, chemogenetic systems offer less invasiveness but slower kinetics.
Activation or inhibition of engineered ion channels by exogenous, inert small molecule ligands (PSEMs), leading to altered cellular excitability via ion flux. The channel is expressed in target cells using genetic methods; activated/inhibited upon administration of a specific exogenous small-molecule agonist/antagonist that does not affect native receptors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Engineered Chemogenetically-Gated Ion Channel.